Arcutis Biotherapeutics, Inc.
ARQT
Classifica tra le azioni
#4069
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Prezzo delle azioni
$31.91
Capitalizzazione di mercato
$4.01B
Variazione (1 giorno)
-2.77%
Variazione (1 anno)
54.61%
Paese
US
Scambia Arcutis Biotherapeutics, Inc. (ARQT)
Categoria
Healthcare
Storico del prezzo dell'azione per Arcutis Biotherapeutics, Inc. (ARQT)
Prezzo di chiusura più alto: $27.20 il 2026-10-01
Prezzo di chiusura più basso: $21.80 il 2020-01-01
Prezzo di chiusura più basso: $21.80 il 2020-01-01
Storico del prezzo dell'azione di Arcutis Biotherapeutics, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -13.12% |
| 2025 | 117.39% |
| 2024 | 438.98% |
| 2023 | -84.13% |
| 2022 | -9.27% |
| 2021 | -38.74% |
| 2020 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
